1-6051641-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001199862.2(KCNAB2):āc.105G>Cā(p.Gln35His) variant causes a missense change. The variant allele was found at a frequency of 0.000484 in 1,534,404 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: š 0.00076 ( 0 hom., cov: 33)
Exomes š: 0.00045 ( 7 hom. )
Consequence
KCNAB2
NM_001199862.2 missense
NM_001199862.2 missense
Scores
5
11
Clinical Significance
Conservation
PhyloP100: 3.78
Genes affected
KCNAB2 (HGNC:6229): (potassium voltage-gated channel subfamily A regulatory beta subunit 2) Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. Four sequence-related potassium channel genes - shaker, shaw, shab, and shal - have been identified in Drosophila, and each has been shown to have human homolog(s). This gene encodes a member of the potassium channel, voltage-gated, shaker-related subfamily. This member is one of the beta subunits, which are auxiliary proteins associating with functional Kv-alpha subunits. This member alters functional properties of the KCNA4 gene product. Alternative splicing of this gene results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Dec 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.009371251).
BP6
Variant 1-6051641-G-C is Benign according to our data. Variant chr1-6051641-G-C is described in ClinVar as [Benign]. Clinvar id is 3055395.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population amr. gnomad4_exome allele frequency = 0.000454 (627/1382020) while in subpopulation AMR AF= 0.017 (605/35682). AF 95% confidence interval is 0.0158. There are 7 homozygotes in gnomad4_exome. There are 263 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 116 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNAB2 | NM_001199862.2 | c.105G>C | p.Gln35His | missense_variant | 2/16 | ENST00000378083.8 | NP_001186791.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNAB2 | ENST00000378083.8 | c.105G>C | p.Gln35His | missense_variant | 2/16 | 2 | NM_001199862.2 | ENSP00000367323 |
Frequencies
GnomAD3 genomes AF: 0.000755 AC: 115AN: 152266Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
115
AN:
152266
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00347 AC: 460AN: 132672Hom.: 7 AF XY: 0.00260 AC XY: 188AN XY: 72312
GnomAD3 exomes
AF:
AC:
460
AN:
132672
Hom.:
AF XY:
AC XY:
188
AN XY:
72312
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000454 AC: 627AN: 1382020Hom.: 7 Cov.: 31 AF XY: 0.000386 AC XY: 263AN XY: 681974
GnomAD4 exome
AF:
AC:
627
AN:
1382020
Hom.:
Cov.:
31
AF XY:
AC XY:
263
AN XY:
681974
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000761 AC: 116AN: 152384Hom.: 0 Cov.: 33 AF XY: 0.000751 AC XY: 56AN XY: 74518
GnomAD4 genome
AF:
AC:
116
AN:
152384
Hom.:
Cov.:
33
AF XY:
AC XY:
56
AN XY:
74518
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
KCNAB2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 28, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationTaster
Benign
D;D;D;D;D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
D
Sift4G
Benign
T
Polyphen
P
Vest4
MutPred
Gain of methylation at R38 (P = 0.0811);
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at